Works matching DE "PROTEINURIA"


Results: 5000
    1
    2
    3

    Elevated urinary fatty acid-binding protein 4 level predicts future renal dysfunction and poor prognosis in Japanese patients with diabetes: a longitudinal cohort study Open Access.

    Published in:
    Clinical Kidney Journal, 2025, v. 18, n. 4, p. 1, doi. 10.1093/ckj/sfaf056
    By:
    • Tanaka, Marenao;
    • Sato, Tatsuya;
    • Gohda, Tomohito;
    • Kamei, Nozomu;
    • Murakoshi, Maki;
    • Ishiwata, Erika;
    • Nakata, Kei;
    • Akiyama, Yukinori;
    • Endo, Keisuke;
    • Kawaharata, Wataru;
    • Aida, Hiroki;
    • Suzuki, Toru;
    • Kubota, Mitsunobu;
    • Sanuki, Michiyoshi;
    • Suzuki, Yusuke;
    • Furuhashi, Masato
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Debilitating fatigue.

    Published in:
    1998
    By:
    • Saunders, Carol S.;
    • Goldberg, Marshall
    Publication type:
    Case Study
    26
    27
    28
    29
    30

    Sirolimus therapy may cause cardiac tamponade.

    Published in:
    Transplant International, 2013, v. 26, n. 2, p. e4, doi. 10.1111/tri.12025
    By:
    • Bertrand, Dominique;
    • Desbuissons, Geoffroy;
    • Pallet, Nicolas;
    • Debure, Alain;
    • Sartorius, Albane;
    • Anglicheau, Dany;
    • Mamzer, Marie-France;
    • Legendre, Christophe;
    • Sberro-Soussan, Rebecca
    Publication type:
    Article
    31
    32

    Proteinuria after kidney transplantation.

    Published in:
    Transplant International, 2012, v. 25, n. 9, p. 909, doi. 10.1111/j.1432-2277.2012.01500.x
    By:
    • Ponticelli, Claudio;
    • Graziani, Giorgio
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    Kidney transplantation in patients with Fabry disease.

    Published in:
    Transplant International, 2009, v. 22, n. 4, p. 475, doi. 10.1111/j.1432-2277.2008.00824.x
    By:
    • Cybulla, Markus;
    • Walter, Kerstin Nanette;
    • Schwarting, Andreas;
    • DiVito, Raffaelle;
    • Feriozzi, Sandro;
    • Sunder-Plassmann, Gere
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1165, doi. 10.1007/s00280-009-0979-8
    By:
    • Yamamoto, Noboru;
    • Tamura, Tomohide;
    • Yamamoto, Nobuyuki;
    • Yamada, Kazuhiko;
    • Yamada, Yasuhide;
    • Nokihara, Hiroshi;
    • Fujiwara, Yutaka;
    • Takahashi, Toshiaki;
    • Murakami, Haruyasu;
    • Boku, Narikazu;
    • Yamazaki, Kentaro;
    • Puchalski, Thomas A.;
    • Shin, Eisei
    Publication type:
    Article
    48
    49
    50